Skip to main content
. 2016 Jan 25;7(6):6424–6435. doi: 10.18632/oncotarget.7024

Table 2. Pathological features of patients enrolled in the study.

Patient # Tumor histology Grading TNM
1 Bladder carcinoma 2 1a
2 Bladder carcinoma 3 1
3 Bladder carcinoma 3 3a
4 Bladder carcinoma 3 Tis
5 Bladder carcinoma 3 3
6 Bladder carcinoma 2 2
7 Bladder carcinoma 3 Tis
8 Bladder carcinoma 3 2
9 Bladder carcinoma 3 2
10 Bladder carcinoma 3 3
11 Bladder carcinoma 3 3b
12 Bladder carcinoma 3 Tis
13 Bladder carcinoma 3 1
14 Bladder carcinoma 3 3a
15 Bladder carcinoma 3 3b
16 Bladder carcinoma 3 3b
17 Bladder carcinoma 2 Ta
18 Bladder carcinoma 3 3
19 Bladder carcinoma 3 3b
20 Bladder carcinoma 3 4b
21 Bladder carcinoma 3 3b
22 Bladder carcinoma 3 2
23 Bladder carcinoma 3 4a
24 Bladder carcinoma 3 3b
25 Bladder carcinoma 2 Tis
26 Bladder carcinoma 2 Tis
27 Bladder carcinoma 3 3a
28 Bladder carcinoma 3 3b
29 Renal cell carcinoma 3 3a
30 Renal cell carcinoma 2 3a
31 Renal cell carcinoma 3 2
32 Renal cell carcinoma 4 2
33 Renal cell carcinoma 4 3a
34 Renal cell carcinoma 3 1
35 Renal cell carcinoma 4 3a
36 Renal cell carcinoma 3 1
37 Renal cell carcinoma 3 1
38 Renal cell carcinoma 2 2b
39 Renal cell carcinoma 3 3
40 Renal cell carcinoma 3 1a
41 Renal cell carcinoma 2 2
42 Renal cell carcinoma 3 3a
43 Renal cell carcinoma 2 3
44 Renal cell carcinoma 2 2
45 Renal cell carcinoma 4 3a
46 Renal cell carcinoma 2 1b
47 Renal cell carcinoma 3 3b
48 Renal cell carcinoma 2 1b